» Articles » PMID: 28903742

Can You Un-ring the Bell? A Qualitative Study of How Affect Influences Cancer Screening Decisions

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2017 Sep 15
PMID 28903742
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The belief that early detection is the best protection against cancer underlies cancer screening. Emerging research now suggests harms associated with early detection may sometimes outweigh the benefits. Governments, cancer agencies, and organizations that publish screening guidelines have found it is difficult to "un-ring the bell" on the message that "early detection is your best protection" because of its widespread communication and enduring resonance. This study explores affective factors-and their interplay with relevant analytical factors-in public/laypersons' decision making about cancer screening.

Methods: A total of 93 people (47 men, 46 women) attended focus groups about, respectively, prostate cancer screening and breast cancer screening in two Canadian cities.

Results: Affective factors were a major influence on many focus group participants' decision making about cancer screening, including fear of cancer and a generalized enthusiasm for prevention/screening, and they were often inspired by anecdotes about the cancer experiences of family and friends. Affect also existed alongside more analytical factors including assessments of reduced risk in the management of any cancer diagnosis if caught early, and, for men, the belief that an unreliable test is "better than nothing," and that men deserve prostate cancer screening because women have breast and cervical cancer screening. Affective factors were particularly noticeable in the sub-groups most supportive of screening and the "early detection" message: older women who felt that mammogram screening should begin at age 40 rather than 50, and older men who felt that prostate cancer screening should be expanded beyond its current unorganized, opportunistic usage. In contrast, younger participants displayed less affective attachments to "early detection" messages and had greater concerns about harms of screening and were more receptive to nuanced messages informed by evidence.

Conclusion: Policymakers attempting to communicate more nuanced versions of the "early detection" message need to understand the role of affect alongside other judgments brought into laypersons' decision making processes and anticipate how affective responses to their messages will be shaped, transformed, and potentially subverted by external forces beyond their control. Particularly overt external factors are campaigns by cancer advocacy organizations actively promoting breast and prostate cancer awareness and screening to younger women and men using affectively-charged messages.

Citing Articles

Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review.

Piessens V, Van den Bruel A, Piessens A, Van Hecke A, Brandt Brodersen J, Lauwerier E PLoS One. 2025; 20(2):e0315247.

PMID: 39899650 PMC: 11790174. DOI: 10.1371/journal.pone.0315247.


Informed choices for some, but not for others: An exploration of Australian midlife women's participation in mammography screening by social class.

Batchelor S, Lunnay B, Macdonald S, Ward P Womens Health (Lond). 2025; 21():17455057241305730.

PMID: 39825767 PMC: 11742167. DOI: 10.1177/17455057241305730.


Acceptability of de-intensified screening for women at low risk of breast cancer: a randomised online experimental survey.

Kelley-Jones C, Scott S, Waller J BMC Cancer. 2024; 24(1):1111.

PMID: 39243000 PMC: 11378402. DOI: 10.1186/s12885-024-12847-w.


Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment.

Kelley Jones C, Scott S, Pashayan N, Morris S, Okan Y, Waller J Med Decis Making. 2024; 44(5):586-600.

PMID: 38828503 PMC: 11283735. DOI: 10.1177/0272989X241254828.


Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.

Pillay J, Guitard S, Rahman S, Saba S, Rahman A, Bialy L Syst Rev. 2024; 13(1):140.

PMID: 38807191 PMC: 11134964. DOI: 10.1186/s13643-024-02539-8.


References
1.
Sirovich B, Schwartz L, Woloshin S . Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?. JAMA. 2003; 289(11):1414-20. DOI: 10.1001/jama.289.11.1414. View

2.
Farrell M, Murphy M, Schneider C . How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing. Eff Clin Pract. 2002; 5(3):120-9. View

3.
Esserman L, Shieh Y, Thompson I . Rethinking screening for breast cancer and prostate cancer. JAMA. 2009; 302(15):1685-92. DOI: 10.1001/jama.2009.1498. View

4.
Gigerenzer G, Mata J, Frank R . Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst. 2009; 101(17):1216-20. PMC: 2736294. DOI: 10.1093/jnci/djp237. View

5.
Ringash J . Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ. 2001; 164(4):469-76. PMC: 80774. View